raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:494550

Squamous cell carcinoma of the larynx

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adolescent, Adult, Childhood, Elderly
Status
active

A rare head and neck tumor characterized by a malignant epithelial neoplasm with evidence of squamous differentiation, most commonly located in the supraglottis or glottis. The tumor can spread directly to adjacent structures or metastasize via lymphatic and blood vessels to regional lymph nodes, or lung, liver, and bones, respectively. Primary risk factors are tobacco smoking and (to a lesser extent) alcohol consumption. Patients may present with hoarseness, dyspnea, stridor, dysphagia, hemoptysis, or odynophagia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSquamous cell carcinoma of the larynx
frCarcinome épidermoïde du larynxCarcinome épidermoïde laryngé
dePlattenepithelkarzinom des LarynxLarynxkarzinom, squamöses
esCarcinoma de células escamosas de la laringe
itCarcinoma a cellule squamose della laringe
nlPlaveiselcelcarcinoom van larynxPlaveiselcelcarcinoom van strottenhoofd
ptCarcinoma de células escamosas da laringe
plRak płaskonabłonkowy krtani
csDlaždicobuněčný (spinocelulární) karcinom hrtanu
ukПлоскоклітинний рак гортані
zh喉鳞状细胞癌
trLarinksin skuamöz hücreli karsinomu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM275355NTBTvalidated
ICD-10C32.8NTBTattributedvalidated
ICD-112C23.10NTBTattributedvalidated
ICD-112C23.20NTBTattributedvalidated
ICD-112C23.30NTBTattributedvalidated
MONDO0005595Evalidated
UMLSC0280324Evalidated
MedDRA10023856Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ING1Disease-causing somatic mutation(s) inAssessedHGNC:6062ENSG0000015348760156613q34inhibitor of growth family member 110866301[PMID]
PTENDisease-causing somatic mutation(s) inAssessedHGNC:9588ENSG0000017186260172810q23.31phosphatase and tensin homolog11801303[PMID]
TNFRSF10BMajor susceptibility factor inAssessedHGNC:11905ENSG000001208896036128p21.3TNF receptor superfamily member 10b9721831[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 100 0004.61 / 100 000EuropeValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]_28687376[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card